In-Depth Characterization and Validation in <i>BRG1</i> -Mutant Lung Cancers Define Novel Catalytic Inhibitors of SWI/SNF Chromatin Remodeling

Zainab Jagani(Novartis (Switzerland)), Margaret E. McLaughlin(Novartis (Switzerland)), Troy Smith(Boston Biomedical Research Institute), Rukundo Ntaganda(Boston Biomedical Research Institute), Rémi Terranova, Robin Ge, GiNell Elliott(Boston Biomedical Research Institute), John Reece-Hoyes(University of Massachusetts Chan Medical School), Gregg Chenail(Boston Biomedical Research Institute), Catherine A. Luu(Joint BioEnergy Institute), François Huet(Boston Biomedical Research Institute), Daniel P. Rakiec, Valérie Dubost(Novartis (Switzerland)), Katsumasa Nakajima(Boston Biomedical Research Institute), Geoffrey Bushold(Boston Biomedical Research Institute), Vera M. Ruda(Boston Biomedical Research Institute), Anthony Vattay(Boston Biomedical Research Institute), Ailing Li(Shanghai Medical College of Fudan University), Gwynn Pardee(Joint BioEnergy Institute), Serena J. Silver(Broad Institute), Christopher D. Adair(Boston Biomedical Research Institute), Simon Mathieu(Boston Biomedical Research Institute), Frederic Sigoillot(Novartis (China)), Xuewen Pan(Baylor College of Medicine), Rie Kikkawa, Jiang Zhu(Chinese PLA General Hospital), Joshua M. Korn(Novartis (United States)), Raviraj Kulathila(Boston Biomedical Research Institute), Tamara J. Gilbert(Pfizer (United States)), Kay X. Xiang(Boston Biomedical Research Institute), David A. Ruddy(Novartis (Switzerland)), Rob Maher, Emily A. Costa(Boston Biomedical Research Institute), Katarina Vulic(Boston Biomedical Research Institute), Anka Bric(Boston Biomedical Research Institute), David Farley(Boston Biomedical Research Institute), Hyo‐eun C. Bhang(Boston Biomedical Research Institute), Linda Bagdasarian(Boston Biomedical Research Institute), Florencia Rago(Boston Biomedical Research Institute), Isabel Park(Boston Biomedical Research Institute), Xiaoling Xie(Division of Materials Science and Engineering), Daniel King(Novartis (United States)), Tiancen Hu, Matt Shirley(Bayer (New Zealand)), Julia Dooley(Boston Biomedical Research Institute), Carsten Russ(Broad Institute), Henrik Moebitz, Scott Clarkson, Qicheng Ma(Boston Biomedical Research Institute), John Cantwell(Joint BioEnergy Institute)
bioRxiv (Cold Spring Harbor Laboratory)
October 22, 2019
Cited by 9


Related Papers